Skip to main content

Medx Health Corp(MDX-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.050
Day High0.050
Open:0.050
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Business Wire
MedX Announces Application for Final Extension of Non-Brokered Private Placement
Business Wire
MedX Announces Application for Extension of Non-Brokered Private Placement
Business Wire
MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes
Business Wire
MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes
Business Wire
MedX Health 2025 YEAR REVIEW
INK Research
Off-market insider buying at MedX Health (MDX)
Company Chart of MDX
Business Wire
MedX Announces Final Closing of Non-Brokered Private Placement
Business Wire
MedX announces Initial Closing and Proposed Extension of Non-Brokered Private Placement
Business Wire
MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development
Business Wire
MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor
Business Wire
MedX Announces Proposed Extension of Non-Brokered Private Placement
Business Wire
MedX Health Corp. Names Meghan Geary as Senior Vice President of Operations
Business Wire
MedX Announces Proposed Non-Brokered Private Placement to Raise up to $2,500,000 and Stock Option Grants
Business Wire
MedX Health Corp. Names John Gevisser as Chief Executive Officer
INK Research
Director buying at MedX Health (MDX)
Company Chart of MDX
Business Wire
MedX Announces the Engagement of Market Maker Consultant
Business Wire
MedX Announces Final Closing of Non-Brokered Private Placement
Business Wire
MedX Announces Further Closing of Non-Brokered Private Placement
Business Wire
MedX Health, Vitamed Biomedical, and Medispa Partner to Expand Teledermatology Services Across Italy

Profile

Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.